RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Showing results 1 to 20 of 41.

Focus Area

Cannabis Research

Focus Area

Substance Use Research

Announcement

RTI International researchers awarded grant funding to explore drugs for chronic pain, cancer

January 08, 2019
RTI In The Media

After 20 Years of Research, RTI Drug Approved for Drug-Resistant Tuberculosis

August 14, 2019 - Triangle Business Journal
RTI In The Media

Research Triangle Park Home to Breakthrough in Combating Drug-Resistant Tuberculosis

November 12, 2019 - CBS 17
Announcement

Researchers Find Combined Therapy for RA May Help Speed Remission

August 21, 2019
News Release

RTI Essential Part of Initiative for Accelerating Research on Possible COVID-19 Treatments

August 12, 2020
News Release

RTI announces follow-up research to groundbreaking PTSD study

May 24, 2022
Impact

Taxol® and Camptothecin™

April 04, 2016
Expert

Elliott Pauli

Event

RTI Fellow Program Distinguished Lecture Series: Doris Rouse presents Public-Private Partnerships to Advance Medical Product Development

January 30, 2023
News Release

FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis

August 14, 2019
Expert

Diana Severynse-Stevens

Event

Southeast Regional Meeting of the American Chemical Society 2023 Annual Meeting

October 25, 2023
Impact

Ulipristal Acetate

April 11, 2016
Focus Area

Preventing Substance Use

Insight

READDI Forethought uses the power of collaboration to accelerate scientific discovery

October 11, 2022
Expert

Sharon Daily

News Release

RTI International Licenses Portfolio of Compounds to APIE Therapeutics

August 25, 2020
Announcement

In Memoriam: Mansukh Wani

April 16, 2020